Centene Corporation Reports Q3 2026 Financial Results and Raises Full-Year Guidance
10/27/2026
Impact: 70
Healthcare
Centene reported third-quarter 2026 revenue of $50.65 billion, GAAP diluted EPS of $(0.14), and adjusted EPS of $0.58. The company raised its full-year 2026 guidance to GAAP EPS above $3.46 and adjusted EPS above $5.20, citing margin recovery and cost controls. Its outlook includes a Health Benefits Ratio of 90.4%–91.1% and interest expenses of $600 million–$620 million, with debt repurchases helping reduce interest costs.
AI summary, not financial advice
Share: